Skip to main content
SpringerLink
Log in

Personalized Treatment of Gynecological Cancer According to Age and Symptom Benefit

  • Chapter
  • First Online:
Personalization in Gynecologic Oncology

Part of the book series: Comprehensive Gynecology and Obstetrics ((CGO))

  • 205 Accesses

Abstract

Since established guidelines for the treatment of gynecological cancers in the elderly are lacking, decisions regarding the treatment plan and policy are currently made in consultation with the patient and family based on the doctor’s experience, referring to data from non-elderly and healthy elderly patients. Recently, a new concept of individualized treatment for gynecological cancer in the elderly has started to be established. In the treatment of cancer in the elderly, patients who can receive the standard treatment applicable to healthy non-elderly patients are considered “fit,” while those who cannot receive such treatment are considered “unfit.” Judgment of suitability requires a comprehensive evaluation of not only individual differences and calendar age, but also physical and mental disabilities, social and economic problems, and medical policy decisions in the case of elderly patients. In particular, when cognitive functions are declining, confirmation of the patient’s intentions can represent an obstacle to determining a treatment plan. In such cases, a comprehensive evaluation of the elderly is used to achieve functional assessment. The purpose of this review was to clarify the current status of surgery and chemotherapy for elderly gynecological cancer patients and to discuss future issues.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Oberaigner W, Minicozzi P, Bielska-Lasota M, Allemani C, de Angelis R, Mangone L, Sant M, Eurocare Working Group. Survival for ovarian cancer in Europe: the across-country variation did not shrink in the past decade. Acta Oncol. 2012;51(4):441–53.

    Article  PubMed  Google Scholar 

  2. Yancik R, Ries LA. Cancer in older persons: an international issue in an aging world. Semin Oncol. 2004;31(2):128–36.

    Article  PubMed  Google Scholar 

  3. Sant M, Chirlaque Lopez MD, Agresti R, Sánchez Pérez MJ, Holleczek B, Bielska-Lasota M, Dimitrova N, Innos K, Katalinic A, Langseth H, Larrañaga N, Rossi S, Siesling S, Minicozzi P, EUROCARE-5 Working Group. Survival of women with cancers of breast and genital organs in Europe 1999–2007: results of the EUROCARE-5 study. Eur J Cancer. 2015;51(15):2191–205.

    Article  PubMed  Google Scholar 

  4. Tew WP, Muss HB, Kimmick GG, Von Gruenigen VE, Lichtman SM. Breast and ovarian cancer in the older woman. J Clin Oncol. 2014;32(24):2553–61. https://doi.org/10.1200/JCO.2014.55.3073.

    Article  PubMed  Google Scholar 

  5. Kluetz P, Chingos DT, Basch EM, et al. Patient-reported outcomes in cancer clinical trials: measuring symptomatic adverse events with the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Am Soc Clin Oncol Educ Book. 2016;35:67–73.

    Article  PubMed  Google Scholar 

  6. LeBlanc TW, Abernethy AP. Patient-reported outcomes in cancer care—hearing the patient voice at greater volume. Nat Rev Clin Oncol. 2017;14(12):763–72.

    Article  PubMed  Google Scholar 

  7. Hightower RD, Nguyen HN, Averette HE, Hoskins W, Harrison T, Steren A. National survey of ovarian carcinoma. IV: Patterns of care and related survival for older patients. Cancer. 1994;73(2):377–83.

    Article  CAS  PubMed  Google Scholar 

  8. Fairfield KM, Lucas FL, Earle CC, Small L, Trimble EL, Warren JL. Regional variation in cancer-directed surgery and mortality among women with epithelial ovarian cancer in the Medicare population. Cancer. 2010;116(20):4840–8.

    Article  PubMed  Google Scholar 

  9. Thrall MM, Goff BA, Symons RG, Flum DR, Gray HJ. Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly. Obstet Gynecol. 2011;118(3):537–47.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Moore KN, Reid MS, Fong DN, Myers TK, Landrum LM, Moxley KM, Walker JL, McMeekin DS, Mannel RS. Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply? Gynecol Oncol. 2008;110(2):133–9.

    Article  PubMed  Google Scholar 

  11. Thrall MM, Gray HJ, Symons RG, Weiss NS, Flum DR, Goff BA. Neoadjuvant chemotherapy in the Medicare cohort with advanced ovarian cancer. Gynecol Oncol. 2011;123(3):461–6. https://doi.org/10.1016/j.ygyno.2011.08.030.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Wimberger P, Lehmann N, Kimmig R, Burges A, Meier W, Hoppenau B, du Bois A, AGO-OVAR. Impact of age on outcome in patients with advanced ovarian cancer treated within a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR). Gynecol Oncol. 2006;100(2):300–7.

    Article  CAS  PubMed  Google Scholar 

  13. Langstraat C, Aletti GD, Cliby WA. Morbidity, mortality and overall survival in elderly women undergoing primary surgical debulking for ovarian cancer: a delicate balance requiring individualization. Gynecol Oncol. 2011;123(2):187–91.

    Article  CAS  PubMed  Google Scholar 

  14. Hershman D, Jacobson JS, McBride R, Mitra N, Sundararajan V, Grann VR, Neugut AI. Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer. Gynecol Oncol. 2004;94(2):540–9. https://doi.org/10.1016/j.ygyno.2004.04.022.

    Article  CAS  PubMed  Google Scholar 

  15. Lin JJ, Egorova N, Franco R, Prasad-Hayes M, Bickell NA. Ovarian cancer treatment and survival trends among women older than 65 years of Age in the United States, 1995–2008. Obstet Gynecol. 2016;127(1):81–9. https://doi.org/10.1097/AOG.0000000000001196.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Fairfield KM, Murray K, Lucas FL, Wierman HR, Earle CC, Trimble EL, Small L, Warren JL. Completion of adjuvant chemotherapy and use of health services for older women with epithelial ovarian cancer. J Clin Oncol. 2011;29(29):3921–6.

    Article  PubMed  Google Scholar 

  17. ESMO. Handbook of cancer in the senior patient. New York: Informa; 2010.

    Google Scholar 

  18. Wildider H. International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol. 2014;32:2595–603.

    Article  Google Scholar 

  19. Ellis G, Whitehead MA, O’Neill D, et al. Comprehensive geriatric assessment for older adults admitted to hospital. Cochrane Database Syst Rev. 2011;7:CD006211.

    Google Scholar 

  20. Robinson TN, Wu DS, Pointer L, et al. Simple frailty score predicts postoperative complications across surgical specialties. Am J Surg. 2013;206:544–50.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Clough-Gorr KM, Stuck AE, Thwin SS, et al. Older breast cancer survivors: geriatric assessment domains are associated with poor tolerance of treatment adverse effects and predict mortality over 7 years of follow-up. J Clin Oncol. 2010;28:380–6.

    Article  PubMed  Google Scholar 

  22. Giannotti C, Sambuceti S, Signori A, et al. Frailty assessment in elective gastrointestinal oncogeriatric surgery: predictors of one-year mortality and functional status. J Geriatr Oncol. 2019;10:716–23.

    Article  PubMed  Google Scholar 

  23. Dale W, Hemmerich J, Kamm A, et al. Geriatric assessment improves prediction of surgical outcomes in older adults undergoing pancreaticoduodenectomy: a prospective cohort study. Ann Surg. 2014;259:960–5.

    Article  PubMed  Google Scholar 

  24. PACE Participants, Audisio RA, Pope D, Ramesh HS, et al. Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol. 2008;65:156–63.

    Article  Google Scholar 

  25. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(M146–56):6.

    Google Scholar 

  26. Balducci L, Stanta G. Cancer in the frail patient. A coming epidemic. Hematol Oncol Clin North Am. 2000;14:235–50.

    Article  CAS  PubMed  Google Scholar 

  27. Saliba S, Elliott M, Rubenstein LA, et al. The Vulnerable Elders Survey (VES-13): a tool for identifying vulnerable elders in the community. JAGS. 2001;49:1691–9.

    Article  CAS  Google Scholar 

  28. Meldon SW, Mion LC, Palmer RM, et al. A brief risk-stratification tool to predict repeatemergency department visits and hospitalizations in older patients discharged from the emergency department. Acad Emerg Med. 2003;10:224–32.

    Article  PubMed  Google Scholar 

  29. Soubeyran P, Bellera C, Goyard J, et al. Validation of the G8 screening tool in geriatric oncology: the ONCODAGE project. J Clin Oncol. 2011;29(suppl; abstr 9001;2011 ASCO Annual Meeting).

    Google Scholar 

  30. Slaets JP. Vulnerability in the elderly: frailty. Med Clin North Am. 2006;90:593–601.

    Article  PubMed  Google Scholar 

  31. Overcash JA, Beckstead J, Moody L, et al. The abbreviated comprehensive geriatric assessment (aCGA) foruse in the older cancer patient as a prescreen: scoring andinterpretation. Crit Rev Oncol Hematol. 2006;59:205–10.

    Article  PubMed  Google Scholar 

  32. Rockwood K, Stadnyk K, MacKnight C, McDowell I, Hebert DBR. A brief clinical instrument to classify frailty in elderlypeople. Lancet. 1999;353:205–6.

    Article  CAS  PubMed  Google Scholar 

  33. Decoster L, Van Puyvelde K, Mohile S, et al. Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations. Ann Oncol. 2015;26:288–300.

    Article  CAS  PubMed  Google Scholar 

  34. Puts MT, Hardt J, Monette J, Girre V, Springall E, Alibhai SM, et al. Use of geriatric assessment for older adults in theoncology setting: a systematic review. JNCI J Natl Cancer Inst. 2012;104:1134–64.

    Article  Google Scholar 

  35. Kenis C, Bron D, Libert Y, et al. Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study. Ann Oncol. 2013;24:1306–12.

    Article  CAS  PubMed  Google Scholar 

  36. Hamaker ME, Jonker JM, de Rooij SE, et al. Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. Lancet Oncol. 2012;13:37–44.

    Article  Google Scholar 

  37. Owusu C, Koroukian SM, Schluchter M, et al. Screening older cancer patients for a Comprehensive Geriatric Assessment: a comparison of three instruments. J Geriatr Oncol. 2011;2:121–9.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Extermann M, Aapro M, Bernabei R, et al. Use of comprehensive geriatric assessmentin older cancer patients: recommendations from the task forceon CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol. 2005;55:241–52.

    Article  PubMed  Google Scholar 

  39. Liuu E, Canouï-Poitrine F, Tournigand C, Laurent M, Caillet P, Le Thuaut A, Vincent H, Culine S, Audureau E, Bastuji-Garin S, Paillaud E, ELCAPA Study Group. Accuracy of the G-8 geriatric-oncology screening tool for identifying vulnerable elderly patients with cancer according to tumour site: the ELCAPA-02 study. J Geriatr Oncol. 2014;5(1):11–9. https://doi.org/10.1016/j.jgo.2013.08.003.

    Article  PubMed  Google Scholar 

  40. Ahmed A, Deng W, Tew W, Bender D, Mannel RS, Littell RD, DeNittis AS, Edelson M, Morgan M, Carlson J, Darus CJ, Fleury AC, Modesitt S, Olawaiye A, Evans A, Fleming GF. Pre-operative assessment and post-operative outcomes of elderly women with gynecologic cancers, primary analysis of NRG CC-002: an NRG oncology group/gynecologic oncology group study. Gynecol Oncol. 2018;150(2):300–5.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Extermann M, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. 2012;118:3377–86.

    Article  PubMed  Google Scholar 

  42. Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011;29:3457–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Mohile SG, Dale W, Somerfield MR, Hurria A. Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology summary. J Oncol Pract. 2018;14(7):442–6. https://doi.org/10.1200/JOP.18.00180.

    Article  PubMed  Google Scholar 

  44. Falandry C, Weber B, Savoye AM, Tinquaut F, Tredan O, Sevin E, Stefani L, Savinelli F, Atlassi M, Salvat J, Pujade-Lauraine E, Freyer G. Development of a geriatric vulnerability score in elderly patients with advanced ovarian cancer treated with first-line carboplatin: a GINECO prospective trial. Ann Oncol. 2013;24(11):2808–13.

    Article  CAS  PubMed  Google Scholar 

  45. Falandry C, Rousseau F, Mouret-Reynier MA, Tinquaut F, Lorusso D, Herrstedt J, Savoye AM, Stefani L, Bourbouloux E, Sverdlin R, D’Hondt V, Lortholary A, Brachet PE, Zannetti A, Malaurie E, Venat-Bouvet L, Trédan O, Mourey L, Pujade-Lauraine E, Freyer G, Groupe d’Investigateurs Nationaux pour l’Étude des Cancers de l’Ovaire et du sein (GINECO). Efficacy and safety of first-line single-agent carboplatin vs carboplatin plus paclitaxel for vulnerable older adult women with ovarian cancer: a GINECO/GCIG randomized clinical trial. JAMA Oncol. 2021;7(6):853–61. https://doi.org/10.1001/jamaoncol.2021.0696.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Ferrero A, Villa M, Tripodi E, Fuso L, Menato G. Can Vulnerable Elders Survey-13 predict the impact of frailty on chemotherapy in elderly patients with gynaecological malignancies? Medicine (Baltimore). 2018;97(39):e12298. https://doi.org/10.1097/MD.0000000000012298.

    Article  Google Scholar 

Download references

Acknowledgments

None

Disclosure

None of the authors have any conflicts of interest to declare in relation to this chapter.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, University of Fukui, Fukui, Japan

    Yoshio Yoshida

  2. Faculty of Medical Sciences, Department of Obstetrics and Gynecology, University of Fukui, Fukui, Japan

    Daisuke Inoue

Authors
  1. Yoshio Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daisuke Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshio Yoshida .

Editor information

Editors and Affiliations

  1. Department of Gynecology and Obstetrics, Graduate School of Med., Kyoto Univ., Kyoto, Japan

    Masaki Mandai

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Yoshida, Y., Inoue, D. (2022). Personalized Treatment of Gynecological Cancer According to Age and Symptom Benefit. In: Mandai, M. (eds) Personalization in Gynecologic Oncology. Comprehensive Gynecology and Obstetrics. Springer, Singapore. https://doi.org/10.1007/978-981-19-4711-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-981-19-4711-7_9

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-19-4710-0

  • Online ISBN: 978-981-19-4711-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation